Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Announces Drug Information Standard Response Letter Writing Services to Support New Product Launches

RALEIGH, N.C., April 30, 2014 /PRNewswire/ -- STEPh, Inc., a full service medical communications company specializing in Competitive Intelligence reports (http://www.stephreports.com), is pleased to announce the expansion of their Drug Information Standard Response Letter (SRL) writing services to support the launch of newly approved products and to assist in the revision of SRLs of currently marketed products. 

Standard Response Letter Creation to Support New Product Launches

STEPh, Inc., specializes in the support of new product launches through the creation of a database of SRLs prior to product launch.  STEPh, Inc., will devise a complete plan for the creation of responses to anticipated product inquiries and will update the responses in a timely manner as new information becomes available.  When necessary, STEPh, Inc., can also assist with other aspects of medical information such as telephone and mail/email support on a contractual basis. 

Revision of Standard Response Letters of Marketed Products

SRLs require continued maintenance to assure that the information being provided to the healthcare community is accurate and current, and in accordance with the most current package insert for that product.  STEPh, Inc., has extensive experience with the maintenance of entire databases of SRLs for marketed products and provides this service on a project or contractual basis.

STEPh, Inc., Qualifications to Provide Medical Information SRL Support

The practice of drug information and the clear and concise conveyance of information about a product is an art that requires specific skills.  Dr. Jay Bauman, President of STEPh, Inc., has over 30 years of experience as a clinician, Director of Medical Information at a top tier pharmaceutical company, and as an author of original research and review articles.  In addition, he is a founding member of the Medical Communications subgroup of the Drug Information Association (DIA) and has personally been involved in the medical information support of more than 2 dozen product launches and their continued support.  He has coordinated international medical information services, given numerous seminars on the art of creation of medical information responses at DIA sponsored meetings, and is a former Editor of the Hospital Edition of US Pharmacist. 

Contact

Further information about pricing for services can be obtained by contacting STEPh, Inc., as noted below:

Dr. Jay H. Bauman
President, STEPh, Inc.
[email protected]
http://www.stephreports.com 
919-818-4942 (cell)

SOURCE Scientific and Technical Evaluation of Pharmaceuticals, Inc.